NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002131

Registered date:29/06/2009

safety and efficacy of chemotherapy combined with radiotherapy for maxillary sinus carcinomas

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedmaxxillary sinus carcinoma
Date of first enrollment2009/06/01
Target sample size10
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)systemic chemoterapy(two cycles,first and fifth week, 5 days ,5FU 800mg/mm3) superselective intraarterial infusion chemotherapy(three cycles CDDP) radiation therapy(50Gy)

Outcome(s)

Primary Outcomesafety
Secondary Outcomeefficacy

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteria1) distant metastasis 2) stenosis or sclerosis of carotid artery 3) 75 years old over

Related Information

Contact

public contact
Name Kazuya Otsu
Address 2-174,Edobashi,Tsu,Mie,514-8507 Japan Japan
Telephone 059-232-1111
E-mail otsu3mk@nifty.com
Affiliation Mie University Graduate School of Medicine Department of Otorhinolaryngology-head and neck surgery
scientific contact
Name Kazuya Otsu
Address 2-174,Edobashi,Tsu,Mie,514-8507 Japan Japan
Telephone 059-232-1111
E-mail otsu3mk@nifty.com
Affiliation Mie University Graduate School of Medicine Department of Otorhinolaryngology-head and neck surgery